HUP0103265A3 - Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use - Google Patents
Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their useInfo
- Publication number
- HUP0103265A3 HUP0103265A3 HU0103265A HUP0103265A HUP0103265A3 HU P0103265 A3 HUP0103265 A3 HU P0103265A3 HU 0103265 A HU0103265 A HU 0103265A HU P0103265 A HUP0103265 A HU P0103265A HU P0103265 A3 HUP0103265 A3 HU P0103265A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- derived peptides
- prosaposin
- cyclic
- cyclic prosaposin
- Prior art date
Links
- 102100036197 Prosaposin Human genes 0.000 title 1
- 101710152403 Prosaposin Proteins 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9835998P | 1998-08-28 | 1998-08-28 | |
PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0103265A2 HUP0103265A2 (hu) | 2002-02-28 |
HUP0103265A3 true HUP0103265A3 (en) | 2002-09-30 |
Family
ID=22268937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0103265A HUP0103265A3 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1105420A1 (hu) |
JP (2) | JP4528443B2 (hu) |
KR (1) | KR20010079695A (hu) |
CN (1) | CN1324367A (hu) |
AU (1) | AU751034B2 (hu) |
BR (1) | BR9913490A (hu) |
CA (1) | CA2341810A1 (hu) |
CZ (1) | CZ2001655A3 (hu) |
HU (1) | HUP0103265A3 (hu) |
IL (1) | IL141586A0 (hu) |
PL (1) | PL204359B1 (hu) |
WO (1) | WO2000012553A1 (hu) |
ZA (1) | ZA200102489B (hu) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
IL141586A0 (en) * | 1998-08-28 | 2002-03-10 | Myelos Corp | Cyclic prosaposin-derived peptide and uses thereof |
AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
EP3357490A1 (en) | 2006-04-28 | 2018-08-08 | Children's Hospital Medical Center | Fusogenic properties of saposin c and related proteins and polypeptides for application to transmembrane drug delivery systems |
BRPI0717475A2 (pt) * | 2006-10-20 | 2014-03-11 | Childrens Hosp Medical Center | Vesículas unilamelares de fosfolipídio elipsoidal de formação espontânea |
CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
CA2982480C (en) | 2015-04-23 | 2021-04-13 | The Procter & Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
MX2018010551A (es) | 2016-03-03 | 2018-11-09 | Procter & Gamble | Composicion anticaspa en aerosol. |
EP3528894A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
US10842720B2 (en) | 2016-10-21 | 2020-11-24 | The Procter And Gamble Company | Dosage of foam comprising an anionic/zwitterionic surfactant mixture |
WO2018075832A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Stable compact shampoo products with low viscosity and viscosity reducing agent |
EP3528897A1 (en) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
CN109862941A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型 |
WO2018075847A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
EP3528898A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam designating hair conditioning benefits |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
WO2019074991A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | COMPACT SHAMPOO COMPOSITION COMPRISING ANIONIC AMINO ACID SURFACTANTS AND CATIONIC POLYMERS |
US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
JP6974928B2 (ja) | 2017-10-10 | 2021-12-01 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | コンパクトなシャンプー組成物 |
WO2019074988A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | METHOD OF TREATING HAIR OR SKIN WITH PERSONAL FOAM COMPOSITION IN THE FORM OF FOAM |
CN111556743B (zh) | 2017-12-20 | 2023-07-18 | 宝洁公司 | 包含硅氧烷聚合物的澄清洗发剂组合物 |
JP2021528410A (ja) | 2018-06-29 | 2021-10-21 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 低界面活性剤エアゾール抗ふけ組成物 |
CA3159404A1 (en) | 2019-12-06 | 2021-06-10 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
US11679065B2 (en) | 2020-02-27 | 2023-06-20 | The Procter & Gamble Company | Compositions with sulfur having enhanced efficacy and aesthetics |
CN116568263A (zh) | 2020-12-04 | 2023-08-08 | 宝洁公司 | 包含恶臭减少材料的毛发护理组合物 |
US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
IL141586A0 (en) * | 1998-08-28 | 2002-03-10 | Myelos Corp | Cyclic prosaposin-derived peptide and uses thereof |
-
1999
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Application Discontinuation
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL141586A0 (en) | 2002-03-10 |
CZ2001655A3 (cs) | 2001-11-14 |
EP1105420A1 (en) | 2001-06-13 |
HUP0103265A2 (hu) | 2002-02-28 |
BR9913490A (pt) | 2001-09-25 |
ZA200102489B (en) | 2002-06-04 |
CN1324367A (zh) | 2001-11-28 |
PL204359B1 (pl) | 2010-01-29 |
CA2341810A1 (en) | 2000-03-09 |
JP2010150272A (ja) | 2010-07-08 |
AU5690599A (en) | 2000-03-21 |
KR20010079695A (ko) | 2001-08-22 |
AU751034B2 (en) | 2002-08-08 |
JP4528443B2 (ja) | 2010-08-18 |
PL346346A1 (en) | 2002-02-11 |
JP2002523518A (ja) | 2002-07-30 |
WO2000012553A1 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
HUP0102372A3 (en) | Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same | |
IL142531A0 (en) | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
HUP0103793A3 (en) | N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them | |
HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
HUP0102579A3 (en) | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use | |
HUP0003592A3 (en) | Lh-rh peptide analogues, their use and pharmaceutical compositions containing them | |
HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
NZ305735A (en) | Cyclic peptide antifungal agents, preparation and pharmaceutical compositions thereof | |
HUP0102515A3 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof | |
HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them | |
HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation |